MRP 330/-STRIP

Composition

Each film coated bilayered tablet contains: Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10 mg + Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Metformin HCL 500 mg (As Extended release ), Excipient q.s.

Doses

As Directed by Physician

Description

it  is primarily used to treat type 2 diabetes mellitus by effectively controlling blood sugar levels through a multi-faceted approach, including increasing urine glucose excretion , stimulating insulin release and suppressing glucagon secretion  and reducing glucose absorption from the intestines and liver production 

Formulation

Tablet